Table Of Contents

1. Introduction 68
1.1. Objectives Of The Study 68
1.2. Market Definition 68
1.3. Overview Of Europe Bio-Implants Market 68
1.4. Currency And Pricing 70
1.5. Limitation 70
1.6. Markets Covered 71
2. Market Segmentation 75
2.1. Markets Covered 75
2.2. Geographic Scope 76
2.3. Years Considered For The Study 77
2.4. Currency And Pricing 77
2.5. Research Methodology 78
2.6. Primary Interviews With Key Opinion Leaders 81
2.7. Secondary Sources 82
2.8. Assumptions 82
3. Market Overview 83
3.1. Drivers 85
3.1.1. Rising Number Of Aging And Geriatric Population 85
3.1.2. Changing Lifestyle Problems 85
3.1.3. Rising Incidence Of Chronic Diseases 86
3.1.4. Increasing Awareness About Cosmetic Implants 87
3.1.5. Technological Advancement In Implants 88
3.1.6. Rising Demand For Non-Surgical Bio-Implants 88
3.2. Restraints 89
3.2.1. High Cost Of Implants 89
3.2.2. Regulatory Scenario 89
3.2.3. Unfavourable Reimbursement Policies 90
3.3. Opportunities 91
3.3.1. Emerging Inclination For Mis Surgeries 91
3.3.2. Growing Number Of Diagnostic Centers And Clinics 92
3.3.3. Emerging Countries 92
3.3.4. Rising Medical Tourism 93
3.4. Challenges 94
3.4.1. Side-Effects Of Various Cosmetic Surgery 94
3.4.2. Lack Of Trained Professionals 94
4. Executive Summary 95
5. Premium Insights 99
6. Europe Bio-Implants Market, By Product Type 101
6.1. Overview 102
6.2. Orthopedics & Trauma 104
6.2.1. Reconstructive Joint Replacements 106
6.2.1.1. Knee Replacement Implants 106
6.2.1.2. Hip Replacement Implants 106
6.2.1.3. Extremities 107
6.2.2. Orthobiologics 109
6.2.2.1. Hyaluronic Acid 109
6.2.2.2. Bone Substitutes 110
6.2.2.3. Bone Growth Factors 110
6.2.2.4. Tissue Implants 110
6.2.2.5. Bone Cement 110
6.2.3. Trauma Implants 111
6.2.3.1. Internal Trauma Fixation Devices 111
6.2.3.2. Craniomaxillofacial Fixation Devices 111
6.2.3.3. Implantable Trauma Stimulators 112
6.2.4. Sports Medicine 112
6.3. Pacing Devices 112
6.3.1. Cardiac Resynchronization Therapy Devices (Crtd) 113
6.3.2. Implantable Cardioverter Defibrillators (Icd) 114
6.3.3. Implantable Cardiac Pacemakers (Icp) 114
6.3.3.1. Single Chambered 115
6.3.3.2. Dual Chambered 115
6.3.3.3. Multiple Chambered 115
6.3.4. Pacing Accessories 115
6.3.4.1. Pacing Leads 116
6.3.4.2. Pacing Batteries 116
6.4. Stents & Related Implants 116
6.4.1. Coronary Stents 118
6.4.1.1. Drug-Eluting Stents 118
6.4.1.2. Bare-Metal Coronary Stents 119
6.4.1.3. Bioabsorbable Stents 119
6.4.2. Peripheral Stents 119
6.4.2.1. Endovascular Stent-Grafts 120
6.4.2.2. Renal & Related Stents 120
6.4.2.3. Femoral & Related Stents 120
6.4.2.4. Carotid Stents 120
6.4.3. Stent-Related Implants 121
6.4.3.1. Synthetic Grafts 121
6.4.3.2. Vascular Grafts 122
6.4.3.3. Peripheral Grafts 122
6.4.3.4. Vena Cava Filters 122
6.5. Spinal Implants 123
6.5.1. Thoracolumbar Implants 124
6.5.2. Intervertebral Spacers 124
6.5.3. Machined Allograft Spacers 125
6.5.4. Cervical Implants 125
6.5.5. Motion Preservation Implants 125
6.5.6. Implantable Spinal Stimulators 125
6.6. Ophthalmic Implants 125
6.6.1. Intraocular Lens 127
6.6.2. Glaucoma & Other Lenses 127
6.7. Structural Cardiac Implants 127
6.7.1. Heart Valves & Accessories 129
6.7.2. Tissue Heart Valves 129
6.7.3. Mechanical Heart Valves 129
6.7.4. Heart Valve Repair Devices 129
6.7.5. Ventricular Assist Device (Vad) 129
6.7.6. Implantable Heart Monitors 130
6.7.7. Insertable Loop Recorders (Ilrs) 130
6.7.8. Implantable Hemodynamic Monitors (Ihm) 130
6.8. Dental Implants 131
6.8.1. Plate Form Dental Implants 132
6.8.2. Root Form Dental Implants 132
6.9. Neurostimulators Implants 133
6.9.1. Cortical Stimulators 134
6.9.2. Deep Brain Stimulators 134
6.9.3. Sacral Nerve Stimulators 134
6.9.4. Spinal Cord Stimulators 135
6.9.5. Vagus Nerve Stimulators 135
6.10. Prosthetic Implants 135
6.10.1. Osseointegration 136
6.10.2. Titanium-Based Prosthetic Implants 136
6.11. Others 137
6.11.1. Gynecological Devices 138
6.11.2. Drug Implants 138
6.11.3. Cosmetic Implants 139
6.11.4. Gastroenterological Implants 139
6.11.5. Urological Implants 139
6.11.6. Skin & Wound Care 139
6.11.7. Otolaryngeal Implants 139
7. Europe Bio-Implants Market, By Type 140
7.1. Overview 141
7.2. Allograft 143
7.3. Autograft 144
7.4. Xenograft 145
7.5. Synthetic 146
7.6. Others 147
8. Europe Bio-Implants Market, By Material 148
8.1. Overview 149
8.2. Biomaterial Metal 151
8.2.1. Titanium 152
8.2.2. Gold 152
8.2.3. Silver 152
8.2.4. Platinum 153
8.3. Alloy 153
8.4. Polymer 154
8.4.1. Natural Polymers 155
8.4.2. Synthetic Polymers 155
8.5. Ceramics 156
8.6. Acrylic Hydrogel 157
9. Europe Bio-Implants Market, Mode Of Administration 158
9.1. Overview 159
9.2. Surgical 161
9.3. Non-Surgical 162
9.3.1. Injectable Fillers/Biomaterials 163
9.3.2. Osteogenic Injectable Bone Substitutes 163
9.3.3. Viscosupplementation 164
9.3.4. Viscoaugmentation 164
10. Europe Bio-Implants Market, By End-User 165
10.1. Overview 166
10.2. Clinics 168
10.3. Hospitals 169
10.4. Ambulatory Surgical Centers 170
10.5. Others 171
11. Europe Bio-Implants Market, By Geography 172
11.1. Europe 173
11.1.1. Germany 195
11.1.2. France 210
11.1.3. U.K. 225
11.1.4. Italy 240
11.1.5. Spain 255
11.1.6. Switzerland 270
11.1.7. Netherlands 285
11.1.8. Belgium 300
11.1.9. Russia 315
11.1.10. Turkey 330
11.1.11. Rest Of Europe 345
12. Europe Bio-Implants Market, Company Landscape 346
12.1. Company Share Analysis; Europe 346
13. Company Profiles 347
13.1. Medtronic 347
13.1.1. Company Overview 347
13.1.2. Revenue Analysis 348
13.1.3. Product Portfolio 349
13.1.4. Recent Developments 350
13.2. Johnson & Johnson Services, Inc. 351
13.2.1. Company Overview 351
13.2.2. Johnson & Johnson Services, Inc.; Revenue Analysis 351
13.2.3. Product Portfolio 352
13.2.4. Recent Developments 352
13.3. Edward Lifesciences Corporation 353
13.3.1. Company Overview 353
13.3.2. Edward Lifesciences Corporation ;Revenue Analysis 353
13.3.3. Product Portfolio 354
13.3.4. Recent Developments 354
13.4. Boston Scientific Corporation 355
13.4.1. Company Overview 355
13.4.2. Boston Scientific Corporation; Revenue Analysis 355
13.4.3. Product Portfolio 356
13.4.4. Recent Developments 356
13.5. Integra Lifesciences Corporation 357
13.5.1. Company Overview 357
13.5.2. Integra Lifesciences Corporation ;Revenue Analysis 357
13.5.3. Product Portfolio 358
13.5.4. Recent Developments 358
13.6. Abbott 359
13.6.1. Company Overview 359
13.6.2. Abbott ;Revenue Analysis 359
13.6.3. Product Portfolio 360
13.6.4. Recent Developments 360
13.7. C. R. Bard, Inc. 361
13.7.1. Company Overview 361
13.7.2. C. R. Bard, Inc.;Revenue Analysis 361
13.7.3. Product Portfolio 362
13.7.4. Recent Developments 362
13.8. Zimmer Biomet 363
13.8.1. Company Overview 363
13.8.2. Zimmer Biomet ;Revenue Analysis 363
13.8.3. Product Portfolio 364
13.8.4. Recent Developments 364
13.9. Biotronik Se & Co. Kg 365
13.9.1. Company Overview 365
13.9.2. Biotronik Se & Co. Kg ;Company Snapshot 365
13.9.3. Product Portfolio 366
13.9.4. Recent Developments 366
13.10. Lifenet Health, Inc. 367
13.10.1. Company Overview 367
13.10.2. Lifenet Health, Inc.;Company Snapshot 367
13.10.3. Product Portfolio 368
13.10.4. Recent Developments 368
13.11. Integrated Orbital Implants 369
13.11.1. Company Overview 369
13.11.2. Integrated Orbital Implants ;Company Snapshot 369
13.11.3. Product Portfolio 370
13.11.4. Recent Developments 370
13.12. Smith & Nephew 371
13.12.1. Company Overview 371
13.12.2. Smith & Nephew ;Revenue Analysis 371
13.12.3. Product Portfolio 372
13.12.4. Recent Developments 373
13.13. Stryker 374
13.13.1. Company Overview 374
13.13.2. Stryker ;Revenue Analysis 374
13.13.3. Product Portfolio 375
13.13.4. Recent Developments 375
13.14. W. L. Gore & Associates, Inc 376
13.14.1. Company Overview 376
13.14.2. W. L. Gore & Associates, Inc ;Company Snapshot 376
13.14.3. Product Portfolio 377
13.14.4. Recent Developments 377
13.15. Valeant Pharmaceuticals International Inc. 378
13.15.1. Company Overview 378
13.15.2. Valeant Pharmaceuticals International Inc.;Revenue Analysis 378
13.15.3. Product Portfolio 379
13.15.4. Recent Developments 379
13.16. Somnomed 380
13.16.1. Company Overview 380
13.16.2. Somnomed ;Revenue Analysis 380
13.16.3. Product Portfolio 381
13.16.4. Recent Developments 381
13.17. Wright Medical Group N.V. 382
13.17.1. Company Overview 382
13.17.2. Wright Medical Group N.V.;Revenue Analysis 382
13.17.3. Product Portfolio 383
13.17.4. Recent Developments 383
13.18. Livanova Plc 384
13.18.1. Company Overview 384
13.18.2. Livanova Plc ;Revenue Analysis 384
13.18.3. Product Portfolio 385
13.18.4. Recent Developments 385
13.19. St. Jude Medical, Inc. (A Subsidiary Of Abbott) 386
13.19.1. Company Overview 386
13.19.2. St. Jude Medical, Inc.;Company Snapshot 386
13.19.3. Product Portfolio 387
13.19.4. Recent Developments 387
13.20. Mimedx Group, Inc. 388
13.20.1. Company Overview 388
13.20.2. Mimedx Group, Inc.;Revenue Analysis 388
13.20.3. Product Portfolio 389
13.20.4. Recent Developments 389
13.21. Cook Group 390
13.21.1. Company Overview 390
13.21.2. Cook Group ;Company Snapshot 390
13.21.3. Product Portfolio 390
13.21.4. Recent Developments 390
14. Related Reports 391